Home / Drug shortages / Riluzole Oral Suspension

Riluzole Oral Suspension — FDA Drug Shortage

Current — EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)

The FDA lists a drug shortage record for Riluzole Oral Suspension (oral suspension) from EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) with status Current. The shortage was first posted on 01/26/2024.

Shortage Details

Status
Current
Company
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)
Package NDC
70726-0304-1
Dosage Form
Oral Suspension
Presentation
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)
Initial Posting
01/26/2024
Revised Date

FDA data resources